6
Participants
Start Date
October 22, 2024
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2029
MVX-ONCO-2
"One administration of MVX-ONCO-2 (or vaccination) consists of the implantation of 2 capsules containing MVX-2 cells and 1 injection of 4 × 10\^6 lethally irradiated autologous tumor cells. Tumor cells will have prealably been harvested from the participant through a surgical procedure.~A full treatment course with MVX-ONCO-2 consists of a total of 6 vaccinations: 4 vaccinations 1 week apart, followed by 2 boosters 2 weeks apart. Capsules are removed 1 week after implantation."
RECRUITING
Hôpitaux Universitaires de Genève, Geneva
University Hospital, Geneva
OTHER